David Moadel


After a Rough Year, It's Time to Reconsider Teladoc Health

As Teladoc Health (TDOC)expands to whole-person virtual care, its stock should provide healthy returns.

It's Just One Awful Update After Another for DiDi Global

Don't try to be a hero with DiDi Global (DIDI) as the downward spiral is likely to continue.

$57 Price Target Could Be Just the Beginning for XPeng

Not everybody is enamored with Chinese stocks right now, but investors should consider investing in electric vehicle manufacturer XPeng (XPEV). Here’s why.

Planned Launches Should Add Fuel to Rocket Lab USA

Rocket Lab USA (RKLB) stock fell almost as quickly as it rose, but November should bring fresh space missions as well as higher share prices.

Progenity Stock Is a Zero-or-Hero Holding for Biotech Bidders

On the heels of a potent patent, short-squeeze target Progenity (PROG) offers excitement - and just maybe, outsized gains - for bold speculators.

Ignore Rumors, Stick to Facts and Hold DiDi Global

Don't hesitate to flex your contrarian muscles and invest in unloved DiDi Global (DIDI) - but first, do your due diligence and forget the FUD.

Out-of-Control Expenses Make It Hard to Smile About SmileDirectClub

SmileDirectClub (SDC) stock may be the target of a pump job by social media traders, but sensible folks should give SmileDirectClub a checkup before i...

After Nasdaq Uplisting, PharmaCyte Biotech Looks Ready to Rumble

There's no denying that PharmaCyte Biotech (PMCB) stock has lost much of its value over the years. However, recent developments could catalyze a price...

Hyliion Stock Anywhere Near $10 Is a Gift You Can't Refuse

Hyliion (HYLN) stock deserves to double or even triple as the electric vehicle manufacturer announces an awesome new long-range, zero-carbon truck.

Scathing Allegations Should Make Investors Nervous About Coinbase Global

Cathie Wood might like Coinbase (COIN) stock, but informed investors should be cautious as a class-action lawsuit pokes holes in Coinbase's reputation...

Take a Chance on Next-Level Luxury EV Market with Churchill Capital IV

Even as Churchill Capital IV (NYSE:CCIV) stock takes a breather, Lucid Motors is reporting intense demand for its flagship vehicle.

Be Like Cathie Wood and Let Skillz Pay the Bills

You can buy Skillz (SKLZ) stock because the CEO of ARK Investment did, but there are other reasons to lean bullish on this mobile e-sports company.

More Authors You Might Like